This metabolite features a PDE selectivity profile just like sildenafil and an in vitro potency for PDE5 approximately fifty% of the mum or dad drug. Plasma concentrations of the metabolite are roughly forty% of those observed for sildenafil, so which the metabolite accounts for about 20% of sildena